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Abstract 
Background: Sri Lanka is a malaria-free country. However it remains surrounded by countries with endemic malaria 
transmission. Since the last indigenous case of malaria was reported in October 2012, only imported malaria cases 
have been diagnosed with 36 cases detected in 2015, which includes 17 cases each of Plasmodium vivax and Plasmo-
dium falciparum and two cases of Plasmodium ovale.
Methods: This study investigated the knowledge and practices regarding malaria chemoprophylaxis among all the 
Sri Lankan security forces personnel returning from peacekeeping missions in malaria endemic countries over a 7 
month period. Adherence to other malaria prevention measures, occurrence of adverse events and incident cases of 
malaria were also recorded maintaining the anonymity of the respondents. Potential associations for non-compliance 
were studied.
Results: Interviews were carried out with 559 security forces personnel returning home from foreign deployments 
in malaria-endemic regions (males: 550, 98.4 %). The majority (553, 98.9 %) was well aware of the need for chemo-
prophylaxis during the overseas stay and its regular use as prescribed. The overall adherence to chemoprophylaxis 
was good with 78.7 % (440/559) reporting regular, as prescribed, use. Having better educational qualifications, being 
female, being prescribed mefloquine, having fever during deployment and belonging to a security force other than 
the army were significantly associated with poor compliance (p < 0.05).
Conclusions: The study reveals that knowledge regarding malaria chemoprophylaxis among Sri Lankan security 
forces personnel serving abroad was good, a fact that may have contributed to absence/extremely low incidence of 
malaria during deployment.
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Background
Malaria has made a comeback in many of the areas 
from which it was previously eliminated during the 
Global Malaria Eradication Programme. This serves as a 
reminder that vigilant systems need to be sustained for 
as long as the mosquito vectors, a suitable climate and 
other conditions exist to facilitate disease transmission 
[1]. The risk of resurgence is determined by the prevail-
ing vectorial capacity (receptivity), the malaria importa-
tion rate (vulnerability), and the malariogenic potential 
[2–4]. Therefore, malaria elimination, once achieved, is 
more likely to be sustained in regions where receptivity is 
low, or in geographically isolated areas with a lower risk 
of imported malaria [4–6].
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Sri Lanka was gripped by a separatist war for nearly 
30 years until 2009, which affected mainly the Northern 
and Eastern parts of the country, leading to frequent 
interruptions of healthcare services in these areas. 
Approximately 60  % (189, 283/336, 640) of malaria 
cases reported in Sri Lanka between the years 2000 
and 2012 were from these areas. Although there has 
been a decline in malaria cases in the country during 
the last 15 years, the number reported among the secu-
rity personnel remained disproportionately high. In 
the last 5  years prior to elimination of local transmis-
sion (2008–2012), 2059 indigenous malaria cases were 
reported in Sri Lanka and 1547 of these (75  %) were 
from the members of the security forces [7]. The con-
flict ended in 2009 and the government had uninter-
rupted access to these regions to continue its malaria 
elimination activities. With that the last indigenous 
case of malaria in Sri Lanka was reported in October 
2012.
Sri Lanka commenced reporting imported malaria 
cases separately since 2008 and the highest number of 
cases (95) was reported in 2013. Malaria surveillance 
takes place to identify early and treat such cases. The 
majority of the cases being imported to Sri Lanka have 
so far originated in India, Pakistan and the continent 
of Africa [8]. Currently security forces personnel serve 
on United Nations peacekeeping missions in malaria 
endemic countries in Africa, South East Asia and the 
Caribbean (Haiti). They also attend training courses in 
India, Bangladesh and Pakistan which report a high num-
ber of malaria cases annually. This has led to a number 
of imported malaria cases being reported from the secu-
rity forces [9]. With a higher proportion of security forces 
personnel involved in missions in malaria endemic coun-
tries, there has been a considerable risk of importation of 
malaria to Sri Lanka.
Malaria chemoprophylaxis is issued free-of-charge 
to travellers by the Anti Malaria Campaign (AMC) 
and remains the most important strategy for prevent-
ing malaria in security forces personnel. The medicines 
currently recommended for chemoprophylaxis by AMC 
are mefloquine 250 mg weekly for those visiting African 
countries and chloroquine base 300 mg weekly for Indian 
subcontinent destinations and Haiti [10].
The objectives of this study were to assess the 
knowledge and practices with respect to malaria pre-
vention among Sri Lankan security forces personnel 
travelling to malaria endemic countries. Rates of com-
pliance with chemoprophylaxis were also investigated 
in security forces personnel returning from their mis-
sions and rates of self-reported adverse events from 
chemoprophylaxis.
Methods
This was a cross sectional study among security forces 
personnel who returned to the country after serving 
or training in malaria endemic countries. The secu-
rity forces personnel included in this paper were mem-
bers of Sri Lankan Army, Air Force, Police and Special 
Task Force (a special unit of the police that are directly 
deployed in combat zones) who were deployed in United 
Nations peacekeeping missions abroad. The calculated 
minimal sample size required was 405 after allowing for a 
5 % non-response rate [11]. However, all returning secu-
rity forces personnel within the period of study (March 
2015–September 2015) were included in the study, with a 
view of further increasing the power of the study as well 
as allowing sub-group analysis. Returnees were inter-
viewed within 2 weeks of their arrival to Sri Lanka.
Following the return of security forces personnel 
from a malaria endemic country, the coordinators of 
the armed forces arranged a meeting with the investiga-
tors. During this interview, data was collected using an 
interviewer-administered questionnaire after obtaining 
informed written consent from the participant. Aware-
ness of chemoprophylaxis, self reported adherence to 
chemoprophylaxis, occurrence of adverse events (AEs), 
mosquito bite prevention methods utilized abroad and 
getting tested for malaria following return to Sri Lanka 
were evaluated using a questionnaire with multiple 
choices. For some questions if the answer was not avail-
able within the given choices, a space was left to write the 
appropriate answer/opinion. If an individual reported 
any neuropsychiatric adverse effects, medically qualified 
investigators were assigned to interview them further. 
The questionnaire was pre-tested on 25 security forces 
personnel who had returned to Sri Lanka prior to the 
commencement of the study.
Chemoprophylaxis was considered as regular if the 
medicines have been taken for the whole duration of 
overseas stay at the recommended dose and intervals; 
irregular, if chemoprophylaxis had been taken at a fre-
quency less than recommended, and interrupted or not 
performed, if chemoprophylaxis had never begun, or had 
been started but subsequently interrupted.
Ethical approval for the study was obtained from the 
Ethics Review Committee of the Faculty of Medicine, 
University of Colombo. Permission for the study was 
also obtained from the Director General (Army Health 
Services), The Commanders of the Air Force and the 
Inspector General of Police. The privacy of respondents 
was ensured during the conduct of interviews. It was 
clearly explained to each of them that disclosing details 
was not a mandatory requirement and that information 
would not be disclosed to a third party including their 
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commanding officers. The information from the inter-
views was not traceable to individual participants.
Data was analysed using SPSS (Version 20, IBM SPSS 
Statistics, USA) software package. Frequencies, propor-
tions, means and standard deviations were used for the 
descriptive analysis. Significance of associations for poor 
compliance was assessed using Chi square test or Fish-
ers exact test, with statistical significance set at 0.05. The 
independent variables were arranged as dichotomous 
categories (degree of freedom − 1) for comparison in Chi 
square test. The associations were also expressed as a risk 
ratio (± 95 % confidence intervals) using the same 2 × 2 
table.
Results
Demography and nature of foreign deployment
The study population comprised 559 security forces 
personnel returning home after foreign deployments in 
malaria endemic overseas territories (males: 550, 98.4 %). 
There were no instances of refusal of consent. The major-
ity (538/559, 96.2 %) was from the Sri Lanka Army. The 
most common foreign station of deployment was Haiti 
(489/559, 87.5 %) and the duration of stay was less than 
6 months for many (546/559, 97.7  %). Other details on 
demography and overseas deployment are summarized 
in Table 1.
Risk factors for malaria
Of the entire sample, two gave a history of confirmed 
malaria during their overseas stay (2/559, 0.4 %), one of 
them acquiring the disease twice. Over 90  % had come 
into contact with a person with malaria within the pre-
ceding 3 months (520/559). None gave a history of a 
blood transfusion within the preceding 3 months.
Knowledge and practices regarding malaria 
chemoprophylaxis
A majority (553/559, 98.9  %) of the sample were well 
aware of the need to start chemoprophylaxis prior to 
departure and the need for its regular use as prescribed 
during the overseas stay. However, more than 80  % 
(459/559) were unaware that the medication had to be 
continued for a specified period of time following return 
to Sri Lanka. Chloroquine had been dispensed to 98.5 % 
of security forces personnel belonging to the Army and 
Air Force and mefloquine was given to eight of twelve 
individuals serving in other forces during their period 
of service in a foreign country. The overall adherence 
to chemoprophylaxis was good with 78.7  % (440/559) 
reporting regular use as prescribed. Of the 110 security 
forces personnel who did not take the medicine regularly 
as instructed, forgetfulness was the main reason for inter-
mittent use (77/110, 70 %). Of the nine individuals who 
did not take prophylaxis at all, five did so despite having 
access to prophylaxis and four did not receive prophy-
laxis prior to departure or at their overseas destination. 
Few individuals with poor compliance (any pattern of use 
other than regular use) (24/115, 20.9  %), reported non-
use due to fear of adverse effects. In spite of a widely held 
perception that malaria chemoprophylaxis is not being 
taken due to the fear of impotency, only five individuals 
gave this as a reason for not taking the drug regularly or 
not at all.
Table 1 Demography and  details of  foreign deployment 
of the sample (n–559)
a G.C.E O/L and A/L—General Certificate of Education Ordinary and Advance 
level examinations, held at 11th and 13th grades of school respectively. The 
latter is the final examination of school education
Characteristic Number (%)
Sex
 Male 550 (98.4)
 Female 9 (1.6)
Ethnicity
 Sinhala 559 (100)
Highest educational qualification
 Up to grade 10 250 (44.7)
 Passed G.C.E. O/L examinationa 207 (37)
 Passed G.C.E. A/L examinationa 60 (10.7)
 Diploma 21 (3.8)
 Graduate 16 (2.9)
 Postgraduate 5 (0.9)
Armed force
 Army 538 (96.2)
 Other forces 21 (3.8)
Rank
 Other ranks 439 (78.5)
 Officers 120 (21.5)
Duration of service in the armed services (years)
 <5 years 3 (0.5)
 6–10 years 224 (40.1)
 11–15 years 86 (15.4)
 16–20 years 166 (29.7)
 21–25 years 66 (11.8)
 >25 years 14 (2.5)
Foreign country of most recent deployment
 Haiti 489 (87.5)
 South Sudan 63 (11.3)
 Liberia 6 (1.1)
 Democratic republic of congo 1 (0.2)
Duration of stay on foreign mission
 >6 months 546 (97.7)
 6–12 months 12 (2.1)
 18–24 months 1 (0.2)
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Of other preventive practices during deployment, the 
most popular methods were the use of mosquito nets, 
mosquito repellents and long sleeved clothing. A major-
ity (522/559, 93.4  %) had used one or more of these 
alternative measures to avoid mosquito bites. Only 37 
(37/559, 6.6 %) said that they did not use any measures to 
avoid mosquito bites. The majority was aware that upon 
return, their blood had to be tested for malaria parasites 
(487/559, 87.1  %) and 550 (550/559, 98.4  %) had their 
blood tested upon return on the advice of the authorities. 
Since the coordinators of the armed forces inform the 
Anti Malaria Campaign officials of the arrival of troops 
from overseas, 99.2 % (546/550) of these tests had been 
conducted at the airport itself on arrival. All nine individ-
uals that missed testing were from one particular force 
and none of them were aware of the need to do a blood 
test for malaria on their return to Sri Lanka. Other details 
regarding knowledge and practices on malaria chemo-
prophylaxis are summarized in Table 2.
Adverse effects
Only 12 (12/550, 2.1  %) of the participants reported 
adverse effects attributable to taking chemoprophylaxis 
regularly. They were all minor reactions including nau-
sea (2/12, 16.6 %) and headache (5, 41.6 %), which did not 
restrict them from continuing to take the medicine. No 
neuropsychiatric adverse effects were reported from the 
eight personnel who took mefloquine.
Malaria infections
Twenty-three (23/559, 4.1  %) reported having had fever 
during their deployment abroad. Two had been diag-
nosed with malaria and both of them were deployed in 
Liberia for 12 months. One of the above had contracted 
Plasmodium falciparum malaria twice during deploy-
ment. The type of malaria was unknown in the second 
person. Of these two individuals one had poor knowledge 
of chemoprophylaxis and had not taken regular chemo-
prophylaxis during or after the deployment. The other 
had no knowledge of chemoprophylaxis and had not 
taken medicines at all to prevent malaria.
Associations of poor compliance with chemoprophylaxis
Being female, having a better education (having passed 
at least G.C.E. O/L examination), being on mefloquine, 
having fever during deployment, belonging to a security 
force other than the Army were significantly associated 
with poor compliance (p  <  0.05). Poor compliance was 
defined as not having regular use of chemoprophylaxis 
as prescribed. Duration of service, rank in the military, 
source of prescription and starting the first dose prior to 
departure were not significantly associated with compli-
ance (Table 3).
Discussion
The strengths and weaknesses of available strategies to 
prevent imported malaria through security forces per-
sonnel returning to Sri Lanka after foreign missions are 
discussed in this manuscript. There had been no cases 
of indigenously acquired malaria in Sri Lanka for over 
3 years. Elimination of malaria is not a one-off achieve-
ment, and constant effort and vigilance is necessary to 
maintain the malaria-free status. The lessons learnt from 
the island nation’s experience in both elimination as well 
as post-elimination surveillance could be valuable for 
other countries in their elimination efforts.
In this regard, this study has been monitoring the tran-
sition of Sri Lanka to a malaria-free nation in collabora-
tion with the National Anti-Malaria campaign and have 
previously published on key strategies to prevent the 
re-introduction by educating population sub groups at 
a high risk of acquiring malaria as well as key response 
groups. These included security forces personnel serving 
in previously endemic areas of the country and medical 
officers serving in previously endemic regions [12, 13].
Security forces are considered a high-risk group for 
imported malaria as large contingencies of Sri Lankan 
security forces personnel have been serving on a rota-
tional basis in United Nations peace-keeping missions 
Table 2 Knowledge and practices regarding malaria chem-
oprophylaxis and surveillance in the sample (n–559)
Knowledge and practices Number (%)
Compliance with chemoprophylaxis
Regular (as prescribed) 440 (78.7)
Intermittent 110 (19.7)
Not taken 5 (0.9)
Medicines were not provided 4 (0.7)
Source of medicines
Doctors of the armed forces 502 (90.4)
Anti Malaria Campaign 7 (1.3)
Doctors of United Nations 5 (0.9)
Nursing officers in the field 8 (1.4)
Pharmacists in the field 6 (1.1)
Other 27 (4.8)
Usage pattern of chemoprophylaxis
First dose taken before departure 520 (94.5)
Change of chemoprophylaxis 6 (1.1)
Continuation of medication following return 31 (5.5)
Usage of other methods to avoid malaria
None 37 (6.6)
Mosquito nets 492 (94.2)
Mosquito repellents and coils 193 (36.9)
Long sleeved cloths 120 (22.9)
Destroy breeding places of mosquitoes 266 (50.9)
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in malaria endemic countries. The socio-economic 
and political turmoils at these locations leave them at 
increased risk of being exposed to malaria [14]. Resist-
ance to first-line anti-malarials are prevalent in many 
African countries (e.g. Central African Republic) the 
troops are deployed [15]. This increases the risk of treat-
ment failure and re-introduction of malaria into Sri 
Lanka.
This study shows that at present, measures to prevent 
importation of malaria by security forces personnel trav-
elling abroad are very satisfactory in most aspects. These 
include; raising awareness of the need for prophylaxis, 
ensuring compliance with chemoprophylaxis and screen-
ing upon re-entry into the country. However, some defi-
ciencies were also noted which can be rectified easily by 
adding extra surveillance steps and health education to 
the existing infrastructure (e.g. educating on the need 
to continue prophylaxis following return to the country 
and continued follow up for malaria for 3–6 months after 
return).
Being in the army was significantly associated with 
better compliance with chemoprophylaxis in this study 
compared to other security forces. None of the Sri Lan-
kan Army personnel had contracted malaria during their 
overseas deployment. The two persons who got infected 
and all individuals who had not been tested upon return 
to the country belonged to another security force group 
which suggests the need of a better mechanism to edu-
cate all security forces personnel serving in Sri Lanka 
on malaria. In the year ending on October 2015, the Sri 
Lanka Army had sent 1058 of its servicemen and women 
to missions abroad. A majority (916/1058, 86.6  %) of 
them had been covered by the Army’s medical units on 
malaria prophylaxis. The administration of prophylaxis is 
done every Sunday under a direct supervision of a medi-
cal officer. Despite the large number of overseas deploy-
ments, the army has reported only five cases of malaria 
for the last 5 years among its troops in overseas deploy-
ment (Personnel Communication, Public Health Special-
ist, Sri Lanka Army). The AMC is notified 2 weeks prior 
to the return of soldiers, due to the close liaison which 
exists between the two organizations. Screening for 
malaria is carried out by both AMC medical officers and 
the Army medical corps at the airport.
Being female and mefloquine use were both associ-
ated with poor compliance in this study. However, the 
numbers in both these categories were few. It is difficult 
to assume the reasons for this observation though it is 
plausible that fear of adverse effects with mefloquine (as 
opposed to the time-tested and popular chloroquine) 
may be a reason. Mefloquine administration for chemo-
prophylaxis has recently come under criticism after 
significant proportion of Australian Defence Force per-
sonnel deployed in East Timor complained of neuropsy-
chiatric adverse events after taking the drug [16, 17]. 
Members of Sri Lankan Army deployed to South Sudan, 
received chloroquine (It has less side effects but is not a 
recommended prophylactic agent for this location [18]) 
due to mefloquine unavailability.
It is interesting that having a better education was 
inversely associated with better compliance in this study. 
Here, it is possible that those with a lower level of edu-
cational qualifications belong to lower ranks, which are 
under strict supervision to take prophylaxis. There was 
no association with belonging to an officer’s rank and 
compliance but the study only examined up to the level 
of a Lieutenant.
Several interesting observations emerge from similar 
studies on malaria chemoprophylaxis in other countries. 
A large scale cross sectional study of peacekeeping forces 
deployed in Afghanistan from 2002 to 2011 evaluated 
the compliance with mefloquine in 5773 participants 
[19]. The compliance was approximately 80 % until 2006 
and dropped to less than 60 % between 2007 and 2011. 
Adverse events were reported by 21.2  % (875/5773) of 
recruits but none were serious. Regular prophylaxis was 
interrupted only in 113 (113/5773, 2.7  %) subjects due 
to adverse effects. No malaria cases were reported dur-
ing deployment in this study. The authors concluded that 
mefloquine was safe for large-scale administration and 
was efficacious even when the overall uptake was not 
optimal. Another study on chemoprophylaxis for sol-
diers in Kenya compared doxycycline against mefloquine 
on the interruption of capacity to work due to adverse 
Table 3 Associations for  poor compliance (any pattern 
of use other than regular use as prescribed)
ns not significant, s significant
** General Certificate of Education—ordinary level
Comparison Risk ratio (95 % confidence 
interval),
p value*
Being male 0.37 (0.2–0.68), 0.02, s
Having passed at least the G.C.E. O/L 
examination** (yes vs. no)
1.6 (1.13–2.25), 0.01, s
Officers vs. others 1.08 (0.96–1.21), 0.207, ns
Army vs. others 0.32 (0.23–0.46), <0.001, s
Duration of service 10 years  
or less vs. others
1.03 (0.95–1.13), 0.528, ns
Being on chloroquine (yes vs. no) 0.27 (0.19–0.39), <0.001, s
Prescribed by an armed forces  
doctor vs. others
1.02 (0.88–1.18), 0.86, ns
Receiving first dose before departure  
(yes vs. no)
1.19 (0.96–1.5), 0.068, ns
Having fever during deployment  
(yes vs. no)
1.9 (1.12–3.26), 0.04, s
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effects [20]. The doxycycline group complained signifi-
cantly more about interruptions to work due to adverse 
effects. However, this study was based on self-reported 
adverse effect profiles. A study on US troops stationed 
in Afghanistan between 2006 and 2007 interviewed 2351 
respondents and the compliance with mefloquine was 
better than that with doxycycline (80 vs. 60 %). A larger 
proportion discontinued doxycycline compared to meflo-
quine (10 vs. 4 %). Doxycycline was unpopular due to its 
dosing regimen (daily dosing as opposed to weekly dos-
ing with mefloquine) and gastrointestinal adverse effects 
[21]. Tunisia is another country that has eliminated 
malaria since 1979. It sends its soldiers for overseas mis-
sions in sub-Saharan Africa. In a hospital-based study 
that assessed the outcome of soldiers diagnosed with 
malaria upon return from 1993 to 2011, 37 cases were 
identified. Chemoprophylaxis was taken by only 21 indi-
viduals (21/37, 41  %) and non-adherence was found as 
the main reason for imported malaria [22]. The compli-
ance rates reported in this study were better than those 
reported in studies elsewhere.
To combat imported malaria it is important to learn 
the strategies employed by other countries. China has 
suffered an increase in imported malaria from 2010 to 
2014 mainly due to expatriates working abroad. Zhou 
et al. [23] describes that chemoprophylaxis alone is inad-
equate to stem the increase, and better awareness and 
education regarding the problem is urgently needed for 
people working overseas [23]. China also shares land 
borders with many countries and lapses in border con-
trol make it difficult to define cases of imported malaria 
from indigenously transmitted cases [23, 24]. Sri Lanka 
being an island does not have such a problem in case 
definition. Greece had been declared malaria free in 1974 
until an outbreak of vivax malaria occurred in Evrotas in 
Southern Greece (a region with a large migrant popula-
tion from malaria endemic countries) in 2011–12 [25]. 
A strategy of mass drug administration (chloroquine 
plus primaquine) for migrants was coupled with active 
case detection, community education and vector control 
measures. No cases of malaria were reported in Evrotas 
in 2013–14 [25]. Spain and Iran are two other countries 
seeing a surge in imported malaria with immigrant influx 
from North Africa and Afghanistan respectively [26, 27]. 
Education of migrants or visitors at border points, allow-
ing them access to voluntary screening and preventive 
or curative health services have worked in Saudi Arabia, 
Thailand and Namibia [28–30]. Though it incurs a cost to 
the host country, on the -erm it can be an investment to 
avoid the costs of a malaria outbreak. Despite the large 
number of visitors received in Saudi Arabia on annual 
Haj pilgrimage from around the world, the country has 
successfully worked towards malaria elimination [28]. 
Regional collaboration between neighbouring countries 
is another effective measure to combat cross border 
malaria. The best example for this would be the Lubombo 
Spatial Development Initiative, which supported insecti-
cide use in Mozambique and Swaziland, which in return 
reduced the malaria incidence in neighbouring South 
African districts by more than 75 % [31]. A similar net-
work between countries providing peace-keeping forces 
and their hosts for sharing of knowledge and healthcare 
costs of treatment, chemoprophylaxis, surveillance and 
other resources would be beneficial to all concerned.
Limitations
This study was based on self-reported compliance rates 
and adverse effect profiles. Unfortunately there were no 
medical records to verify these claims. While some sig-
nificant associations for poor compliance were noted, the 
exact cause for these observations could not be estab-
lished. Such an analysis would require an in depth quali-
tative study which was not the objective. Security forces 
are, by nature, hierarchical institutions and the fear of 
punishment in case of admitting non-compliance might 
have biased the reported compliance rates. The sample 
was dominated by respondents from the Army, which 
also happens to have a good health education and sur-
veillance programme in place. The observed compliance 
rates might have been different if the sample had an equal 
number of participants from all security forces.
Conclusions
In this study of Sri Lankan security forces personnel return-
ing home from serving in overseas malaria endemic territo-
ries, the rate of malaria infections was found to be very low. 
The self-reported compliance with chemoprophylaxis was 
also satisfactory. A coordinated effort between the individ-
ual security forces and the National Anti Malaria Campaign 
ensured that security forces personnel were educated prior 
to departure, provided with appropriate chemoprophy-
laxis and screened upon re-entry to the country helping to 
keep the number of imported malaria cases to a minimum 
in this high-risk group. Such a coordinated effort is highly 
recommended for other countries contributing peacekeep-
ing forces to malaria endemic countries to avoid cases of 
imported malaria.
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